Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?

被引：0
|
作者：
Carla GS Saad
Ana CM Ribeiro
Julio CB Moraes
Liliam Takayama
Celio R Goncalves
Marcelo B Rodrigues
Ricardo M de Oliveira
Clovis A Silva
Eloisa Bonfa
Rosa MR Pereira
机构：
[1] Faculdade de Medicina da Universidade de São Paulo,Division of Rheumatology
[2] Faculdade de Medicina da Universidade de São Paulo,Department of Radiology
[3] RDO Diagnósticos Médicos,undefined
来源：
Arthritis Research & Therapy | / 14卷
关键词：
Bone Mineral Density; Ankylose Spondylitis; Spine Bone Mineral Density; Lumbar Spine Bone Mineral Density; Bath Ankylose Spondylitis Disease Activity Index;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 16 条
  • [1] Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapy
    Martin Rudwaleit
    Filip Van den Bosch
    Martina Kron
    Sonja Kary
    Hartmut Kupper
    Arthritis Research & Therapy, 12
  • [2] Clinical response to discontinuation of anti-tumor necrosis factor therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab
    Baraliakos, X.
    Listing, J.
    Brandt, J.
    Rudwaleit, M.
    Sieper, J.
    Braun, J.
    ARTHRITIS RESEARCH & THERAPY, 2005, 7 (Suppl 1) : S14 - S14
  • [3] Dickkopf-1 level is lower in patients with ankylosing spondylitis than in healthy people and is not influenced by anti-tumor necrosis factor therapy
    Kwon, Seong-Ryul
    Lim, Mie-Jin
    Suh, Chang-Hee
    Park, Shin-Goo
    Hong, Yeon-Sik
    Yoon, Bo-Young
    Kim, Hyoun-Ah
    Choi, Hyo-Jin
    Park, Won
    RHEUMATOLOGY INTERNATIONAL, 2012, 32 (08) : 2523 - 2527
  • [4] Clinical response to discontinuation of anti-tumor necrosis factor therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab
    X Baraliakos
    J Listing
    J Brandt
    M Rudwaleit
    J Sieper
    J Braun
    Arthritis Research & Therapy, 7
  • [5] Anti-tumor Necrosis Factor Therapy Increased Spine and Femoral Neck Bone Mineral Density of Patients with Active Ankylosing Spondylitis with Low Bone Mineral Density
    Li, Haibo
    Li, Qiuxia
    Chen, Xi
    Ji, Chen
    Gu, Jieruo
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (08) : 1413 - 1417
  • [6] Effect of Tumor Necrosis Factor Inhibitor Therapy on Osteoclasts Precursors in Ankylosing Spondylitis
    Perpetuo, Ines P.
    Raposeiro, Rita
    Caetano-Lopes, Joana
    Vieira-Sousa, Elsa
    Campanilho-Marques, Raquel
    Ponte, Cristina
    Canhao, Helena
    Ainola, Mari
    Fonseca, Joao E.
    PLOS ONE, 2015, 10 (12):
  • [7] Clinical response to the anti-tumor necrosis factor alpha antibody infliximab in patients with ankylosing spondylitis over 3 years
    Barallakos, X.
    Brandt, J.
    Listing, J.
    Sieper, J.
    Braun, J.
    ARTHRITIS RESEARCH & THERAPY, 2005, 7 (Suppl 1) : S14 - S14
  • [8] Clinical response to the anti-tumor necrosis factor alpha antibody infliximab in patients with ankylosing spondylitis over 3 years
    X Baraliakos
    J Brandt
    J Listing
    J Sieper
    J Braun
    Arthritis Research & Therapy, 7
  • [9] The inadequate anti-tumour necrosis factor (anti-TNF) therapy in patients with ankylosing spondylitis
    Pinar Borman
    Figen Ayhan
    Esma Ceceli
    Rheumatology International, 2010, 30 : 1689 - 1690
  • [10] The inadequate anti-tumour necrosis factor (anti-TNF) therapy in patients with ankylosing spondylitis
    Borman, Pinar
    Ayhan, Figen
    Ceceli, Esma
    RHEUMATOLOGY INTERNATIONAL, 2010, 30 (12) : 1689 - 1690
12